Baker Brothers Advisors - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 45 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$36,577,000
-4.6%
29,174,0000.0%0.21%
-5.5%
Q1 2022$38,359,000
-10.2%
29,174,0000.0%0.22%
+5.8%
Q4 2021$42,695,000
-1.1%
29,174,0000.0%0.21%
+9.5%
Q3 2021$43,167,000
+12.2%
29,174,0000.0%0.19%
+12.4%
Q2 2021$38,479,000
+221.5%
29,174,000
+218.0%
0.17%
+225.0%
Q1 2021$11,970,0009,174,0000.05%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
DLD Asset Management, LP 10,370,000$17,732,7001.93%
CSS LLC/IL 8,157,000$13,813,8470.86%
Worth Venture Partners, LLC 917,000$1,562,0520.85%
TENOR CAPITAL MANAGEMENT Co., L.P. 5,198,000$8,887,1870.19%
BOOTHBAY FUND MANAGEMENT, LLC 2,495,000$4,354,5550.10%
Point72 Asset Management, L.P. 9,007,000$15,327,3320.05%
PALISADE CAPITAL MANAGEMENT, LP 1,000,000$1,696,2500.04%
CAPSTONE INVESTMENT ADVISORS, LLC 5,082,000$8,580,1430.04%
SSI INVESTMENT MANAGEMENT LLC 141,000$237,7030.02%
LORD, ABBETT & CO. LLC 3,005,000$5,0660.02%
View complete list of SAREPTA THERAPEUTICS INC shareholders